FDA Inspection
Raybow (Suzhou) Pharmaceutical Co., Ltd.Raybow (Suzhou) Pharmaceutical Co., Ltd. – FDA Inspection, May 22, 2025
Record Details
This FDA Inspection record concerns Raybow (Suzhou) Pharmaceutical Co., Ltd., with an inspection on May 22, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · b5c82a64-8301-4677-9693-560497a8fa17
Inspection Facts
- Inspection number
- 1273595
- FDA center
- Human Drugs
Other FDA inspections of Raybow (Suzhou) Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 18, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 25, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Raybow (Suzhou) Pharmaceutical Co., Ltd.
- FDA Inspection 1071681 - 2018-10-18
- FDA Inspection 910769 - 2014-09-19
- FDA Inspection 671664 - 2010-05-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.